GK
Gurpreet Kaur
About Gurpreet Kaur
Data last updated:
Gurpreet Kaur is a Director at Medwaala Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Medwaala Pharmaceuticals Private Limited reported revenue of ₹57.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Feb 2020 | 2017 | ₹57.4 Lakh (FY 2024) | Active |
Board colleagues of Gurpreet Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gurmeet Singh | 07673673 | Medwaala Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurpreet Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurpreet Kaur
Gurpreet Kaur currently holds 1 directorship: Medwaala Pharmaceuticals Private Limited (Director, since 21 Feb 2020, revenue ₹57.4 Lakh (FY 2024)).
Gurpreet Kaur was first appointed on 21 Feb 2020 as Director at Medwaala Pharmaceuticals Private Limited.
The current boards of Gurpreet Kaur's companies include Gurmeet Singh (Medwaala Pharmaceuticals Private Limited).